Commenting that “A five-year-old’s complaint that she has an earlier bedtime than her brother does not create a plausible inference that she is being treated unfairly if her brother is a senior in ...

Novo Nordisk has taken an interest in a weight-loss implant developed by Californian medtech Vivani Medical, reflecting a broadening of the drugmaker’s strategy to fend off mark ...

The former ESPN and MSNBC anchor had a restored T206 Honus Wagner with a mysterious provenance, it's now been slabbed as ...

The company argues that claims of underperformance should be judged against a meaningful, comparable benchmark.

Many students see the equal sign as a signal to calculate, rather than a symbol of equivalence. Here’s how to clear up that ...

No vaccine-related serious adverse events (SAEs) or sustained Grade 3 or higher adverse events related to the vaccine reportedSOUTH SAN ...

The tables have turned for the U.S. biosimilars market. With more than a decade since the first FDA biosim approval, strong launches to biologic copies to AbbVie’s Humira, J&J’s Stelara and ...

VRBPAC endorsed mRNA-1010 for adults 50-64 and ≥65 years, unanimously concluding benefits outweighed risks, supporting a late-stage regulatory path toward potential first mRNA seasonal influenza ...

School-based programmes may prevent adolescents from starting to use electronic cigarettes (e-cigarettes) and a community-based programme delivered by text message probably helps adolescents quit ...

Many of the FDA’s decisions this quarter involve applications that have previously been delayed, declined or outright ...

Semaglutide does not appear to increase the risk of developing neovascular age-related macular degeneration in patients with type 2 diabetes.

Cefazolin demonstrated equivalent survival rates and lower kidney injury risks compared to standard antistaphylococcal ...